Please login to the form below

Not currently logged in
Email:
Password:

US CROs to report payments to physicians

New rules to US ‘Sunshine Act’ also apply to CMOs

US contract research organisations (CROs) and contract manufacturing organisation (CMOs) must now declare any payments made to physicians, under new federal regulations impacting the pharmaceutical industry.

The Transparency Report and Reporting of Physician Ownership or Investment Interests, commonly known as the 'Sunshine Act', will require manufacturers of drugs, devices, biological or medical supplies to report payments made to physicians on an annual basis.

The new rules fall under the Patient Protection and Affordable Care Act (ACA) section of the act and apply to companies functioning within US health programmes Medicare, Medicaid or CHIP.

The ruling, released last week, also applies to both CMOs and CROs and will cover "payments and transfers of value", including consulting fees, honoraria, gifts, travel and entertainment.

From August 2013 companies will need to begin collecting data on payments made to physicians, which will then be submitted to the Department of Health and Human Services' (HHS) Centers for Medicare and Medicaid Services (CMS), by the end of March 2014.

"The intent of this law is to bring potential conflicts of interest to light with the goal of driving down healthcare costs," explained Scott Liebman, principal at Porzio, Bromberg & Newman, speaking to Forbes.

14th February 2013

From: Research, Regulatory

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
M3 (EU)

M3 was founded in 2000 with the goal of changing the world of medicine through making full use of the...

Latest intelligence

OPEN Health expands offering with the launch of a new Learning & Development specialist team
Enhanced expertise to deliver impactful internal training programmes for healthcare clients...
Figure 1 Clarivate
The changing nature of approvals – what does the future hold?
The 2019 CMR International Pharmaceutical R&D Factbook...
Spotlight interview: 15 minutes on healthcare communications in gene therapy
Gavin Jones, Director of Rare Disease, OPEN Health takes 15 minutes to answer some key questions on healthcare communications in gene therapy...

Infographics